PMA Graphene Technology Group Inc. PMA
Set alert
1.35 USD +0.05 +3.85%
As of Nov 2, 2:15 PM ET
1.25 Day range 1.35
0.60 52-week range 2.38
- YTD
- +35.00%
- 1 year
- -41.56%
- Open
- 1.32
- Prev close
- 1.30
- Mkt cap
- 220.02M
- Vol
- 9.32K
- Avg vol
- 134.14K
- EPS
- -0.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.25
- High
- 1.35
1M chart
Signals (13)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 29, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 29, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 27, 2026 | 6 days ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
Financials — quick view
PMA Revenue — annual 14.63M
PMA Net income — annual -5.76M
PMA EPS — annual -0.44
News
- PMA Graphene Technology Group Inc. Announces Leadership Changes and Appointment of Mr. Lei Liu as Chief Executive Officer
- Ming Shing Group Holdings Limited Announces Closing of the Acquisition of Meals Through Seasons Limited and Issuance of Consideration Shares and Unsecured Convertible Promissory Notes
- Ming Shing Group Receives Non-Compliance Notice From Nasdaq; Granted 45 Days To Submit Plan To Regain Compliance
- Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II
- 12 Industrials Stocks Moving In Thursday's Intraday Session
- 12 Industrials Stocks Moving In Wednesday's After-Market Session
- 12 Industrials Stocks Moving In Wednesday's Intraday Session
- 12 Industrials Stocks Moving In Wednesday's Pre-Market Session
- Ming Shing Group Holdings Limited Announces Entering into Stock Purchase Agreement
- GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
Your note
Sign in to keep a note on PMA — it syncs with the Stock Master app.